This funding round has closed.
3 later rounds of Contracts for Innovation are open, or sign up for alerts.
Contracts for Innovation: industrial human-relevant drug models
One round of Contracts for Innovation, which has run 9 rounds in total and has 3 open now.
Funding
£80,000 – £200,000
Applications
Open until 15 April 2026
Innovate UK is offering £2 million to develop alternatives to animal testing for new medicines. You can apply for between £80,000 and £200,000 to create non-animal methods for testing drug safety. The focus is on testing how drugs move through the body and their effects on the heart. This funding is for developing and commercialising these new testing methods. The deadline is 15 April 2026. Projects must be based in England. This is part of efforts to reduce animal testing in drug development.
Key requirements:
- Must develop non-animal methods for drug testing
- Must focus on pharmacokinetics and cardiovascular safety
This grant is for organisations working in health and medical research in England. You should be developing alternatives to animal testing for medicines. It suits research companies, biotech firms, and organisations with expertise in drug safety testing.
Full details from Innovate UK
Organisations can apply for a share of £2 million, inclusive of VAT, to develop and commercialise non‑animal methods for assessing the pre‑clinical pharmacokinetics and cardiovascular safety of new medicines.
Get notified about grants like this
Create a free account to receive alerts when new charities & non-profit funding opens.
Create free accountSimilar live grants
Support for Victims and Survivors of Child Sexual Abuse Fund 2027 - 2029
Home Office
£2,999,999 – £3,000,000
Thriving Communities Fund - Sustainability Grant
London Borough of Hounslow
Request for proposals: TVET landscape study in Nigeria
British Council
Sunrise Moments Community Fund
Sunrise Medical
Up to £5,000
Farming Futures R&D fund: Automation and Robotics Round 2
Defra and Innovate UK
£1,000 – £1,225,000
Last updated: 16 April 2026